We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  FREE
Dror Soffer, MD; Josef Klausner, MD; Dan Bar-Zohar, MD; et al.
Arch Surg. 2008;143(10):983-989. doi:10.1001/archsurg.143.10.983.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Targeting Prodromal Alzheimer Disease With Avagacestat A Randomized Clinical Trial
Vladimir Coric, MD; Stephen Salloway, MD; Christopher H. van Dyck, MD; et al.
JAMA Neurology
Editorial  | 
Neurogranin Levels in Cerebrospinal Fluid A New Addition to the Alzheimer Disease Diagnostic Toolbox
Henrik Zetterberg, MD, PhD; Kaj Blennow, MD, PhD
JAMA Neurology
Original Investigation  | 
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I. Kester, MD, PhD; Charlotte E. Teunissen, PhD; Daniel L. Crimmins, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Copyright and Bedside Cognitive Testing Why We Need Alternatives to the Mini-Mental State Examination
John C. Newman, MD, PhD